Historical record - last NADAC effective date: 3/20/2024
Product Information
CEFDINIR 300 MG CAPSULE is a generic product labeled by Sandoz Inc., priced at $0.5003 per EA under NDC 00781217660. Its NADAC has been published 540 times since Nov 28, 2013.
FDA first approved this application on Apr 6, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Sandoz Inc.NDC
00781217660
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
3/20/2024
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA065330FDA Approved
4/6/2007
TE Code
AB
On Market Since
4/6/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 300 MG CAPSULE has been published 540 times since Nov 28, 2013, and over the history we have for it it has declined 62.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5003 per EA |
|---|---|
| All-time high | $1.3888 (Feb 12, 2014) |
| All-time low | $0.4325 (Jan 18, 2023) |
| Median price | $0.5346 |
| Average price | $0.6795 |
| Largest weekly change | +50.2% (Feb 22, 2017) |
| Weeks tracked | 540 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+6.2%
5Y
-6.6%
All
-62.8%
Last surveyed Mar 27, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFDINIR 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 300 MG CAPSULE, manufactured by Sandoz Inc., is $0.5003 per EA (NDC 00781217660), effective Mar 27, 2024.
How has the price of CEFDINIR 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFDINIR 300 MG CAPSULE has declined 62.8%. It has been tracked across 540 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFDINIR 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CEFDINIR 300 MG CAPSULE has ranged from a low of $0.4325 (Jan 18, 2023) to a high of $1.3888 (Feb 12, 2014), with a median of $0.5346 per EA.
Are there cheaper alternatives to CEFDINIR 300 MG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFDINIR 300 MG CAPSULE, is $0.4593 per EA — about 8% below CEFDINIR 300 MG CAPSULE.
Who manufactures CEFDINIR 300 MG CAPSULE?
CEFDINIR 300 MG CAPSULE (NDC 00781217660) is labeled by Sandoz Inc., and CMS classifies it as a generic product.